← Back
▼ SELL 10b5-1 Plan

$ Value

$23K

Shares

122

Price

$191

Filed

Mar 17

Insider

Name

Chapman Rowan E

Title

CIK

0001786240

Roles

Director

Transaction Details

Transaction Date

2026-03-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,752

Footnotes

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

Filing Info

Accession No.

0001786240-26-000003

Form Type

4

Issuer CIK

0001604821

Chapman Rowan E's History

Date Ticker Type Value
2026-03-13 NTRA $23K
2026-01-30 NTRA A
2025-12-05 NTRA M $129K
2025-12-05 NTRA $972K
2025-12-05 NTRA $89K
2025-12-05 NTRA M $0
2025-10-31 NTRA A
2025-08-28 NTRA $459K
2025-07-25 NTRA A
2025-06-27 NTRA A

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E 2026-01-30
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10